impact of novel agents on coverage decisions in cll
Published 8 years ago • 40 plays • Length 3:56Download video MP4
Download video MP3
Similar videos
-
24:17
combination of novel agents in cll: is this the final answer?
-
2:12
the impact of genetic abnormalities on treatment decisions in cll
-
6:00
impact of prognostic factors on clinical decisions in cll
-
1:50
the impact of ighv mutational status in treatment decisions in cll
-
1:01
cll resistance mechanisms in the era of novel agents
-
1:21
how the concept of fitness in cll has changed with the introduction of novel targeted agents
-
21:13
breakthrough cll treatments: the latest advances in chronic lymphocytic leukemia | the patient story
-
17:13
chronic lymphocytic leukemia treatment & side effects (venetoclax & obinutuzumab) | tamsin (3 of 3)
-
1:01:37
new treatment guidelines to chronic lymphocytic leukemia (cll): latest advances & treatments
-
1:12
the reduced prognostic impact of the cll-ipi in the new era of targeted agents
-
1:31
impact of novel treatment options on long-term outcomes in cll and wm
-
3:51
the role of frontline chemoimmunotherapy in the era of novel agents in cll
-
1:15
dr. piers blombury discusses fcr, novel agents and advances in cll treatment
-
1:55
novel agents in cll: the importance of affordability
-
2:01
impact of comorbidities on patient selection for combination therapies in cll
-
1:12
side effects of novel drugs and managing patient expectations in cll
-
1:51
understanding and overcoming resistance mechanisms to novel agents used in cll
-
2:08
disease characteristics impacting treatment decisions in cll
-
16:24
chemotherapy vs novel agents in young cll patients: is there still a role for chemo?